STOCK TITAN

Natera (NTRA) chief legal officer acquires 6,902 shares via option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Natera, Inc. reported an insider transaction by an officer serving as its SEC. and Chief Legal Officer. On December 4, 2025, this officer exercised stock options to acquire 6,902 shares of Natera common stock at an exercise price of $19.68 per share, converting derivative securities into common stock.

Following the transaction, the officer directly beneficially owned 208,601 shares of Natera common stock. The filing also shows 5,598 remaining stock options with a $19.68 exercise price, expiring on March 21, 2029, and notes that the option shares are fully exercisable.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
RABINOWITZ DANIEL

(Last) (First) (Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)
AUSTIN TX 78753

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SEC. AND CHIEF LEGAL OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
12/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/04/2025 M 6,902 A $19.68 208,601 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $19.68 12/04/2025 M 6,902 (1) 03/21/2029 Common Stock 6,902 $0 5,598 D
Explanation of Responses:
1. The option shares are fully exercisable.
/s/ Vincent Fontanilla, Attorney-in-Fact 12/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Natera (NTRA) report in this filing?

Natera reported that its SEC. and Chief Legal Officer exercised stock options on December 4, 2025 to acquire 6,902 shares of common stock.

How many Natera (NTRA) shares were acquired and at what price?

The officer acquired 6,902 Natera common shares at an exercise price of $19.68 per share through a stock option exercise.

How many Natera (NTRA) shares does the officer own after the transaction?

After the reported transaction, the officer directly beneficially owned 208,601 shares of Natera common stock.

What happened to the stock options exercised in this Natera (NTRA) transaction?

Stock options covering 6,902 shares were exercised and converted into common stock, as reflected in both the non-derivative and derivative security tables.

How many Natera (NTRA) stock options does the officer still hold?

The filing shows 5,598 remaining stock options beneficially owned by the officer following the transaction.

When do the remaining Natera (NTRA) stock options held by the officer expire?

The remaining stock options, with an exercise price of $19.68, have an expiration date of March 21, 2029.

What is the reporting persons role at Natera (NTRA)?

The reporting person is identified as an Officer of Natera, serving as its SEC. and Chief Legal Officer.

Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

32.85B
133.64M
3.2%
96.35%
2.7%
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN